Back

Severe tricuspid regurgitation under contemporary medical therapy: a cohort analysis of the cardiorenal phenotype

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Baseline assessment of tricuspid regurgitation Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Layal Mansour

Hospital Pontchaillou of Rennes, Rennes (France)

6 More presentations in this session

Presentation thumbnail
Clinical utility of non-invasive right ventricular pressure–strain loops for functional assessment and risk stratification in pulmonary hypertension
Doctor L. Liu (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Clinical features of late-onset pulmonary hypertension after successful left-sided valve surgery
Assistant Professor A. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Hemodynamic phenotypes and clinical outcomes in patients with severe tricuspid regurgitation
Doctor S. Frydman (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Impact of tricuspid regurgitation severity on the agreement between Fick and thermodilution cardiac output measurements
Doctor D. Matan (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Accuracy of echocardiographic hemodynamic assessment compared to right heart catheterization: results from the TECH prospective multicentric registry
Doctor A. Tripoli (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Baseline assessment of tricuspid regurgitation

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Transcatheter tricuspid valve repair: long-term survival and economic implications in a German real-world cohort
28 August 2026
thumbnail
Congress Presentation
Official start of the congress
18 March 2022
thumbnail
Congress Presentation
Hypertrophic cardiomyopathy reshapes cardiomyocyte extracellular vesicle output and composition to promote inflammation and extracellular matrix remodelling
31 August 2026
thumbnail
Congress Presentation
Early in-hospital initiation of dapagliflozin versus empagliflozin in acute heart failure: impact on in-hospital survival and safety
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources